The 2026 Mid-Year Non-Dilutive Funding Landscape Report
The first half of 2026 was the most disruptive period in SBIR history. A six-month lapse, a $30M new award mechanism, record-low NIH success rates, $1.27B in CDMRP funding, and a tightening VC market. Here’s the full data picture — and what it means for your funding strategy.
